---
title: "MicroBioAgent: autonomous AI for end-to-end microbiome analysis"
id: "biorxiv-3-microbioagent-an-ai-agent-for-automated-microbiome-analysis"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-3-microbioagent-an-ai-agent-for-automated-microbiome-analysis"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.17.767465v1?rss=1"
published_at: "2026-11-21T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# MicroBioAgent: autonomous AI for end-to-end microbiome analysis
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-3-microbioagent-an-ai-agent-for-automated-microbiome-analysis
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.17.767465v1?rss=1)
- **Published At:** 2026-11-21T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- MicroBioAgent is a domain-specific autonomous agent that converts high-level biological questions into executable, study-specific microbiome pipelines. - The framework supports three analysis modes: **16S rRNA amplicon**, reference-based shotgun, and de novo assembly–based **metagenomics**, selecting tools dynamically rather than using static templates. - Investigators implemented a closed-loop execution architecture that inspects intermediate outputs and adapts downstream steps during runtime, allowing iterative decision-making across multi-step workflows. - To handle long-running computations, the team added an asynchronous background task-management mechanism that reduced LLM token consumption by over 50% while permitting real-time plan adjustment and automatic workflow resumption. - The authors evaluated MicroBioAgent on three benchmarks of rising complexity: tomato rhizosphere paired amplicon/shotgun profiling; colorectal cancer taxonomic/functional profiling with machine-learning classification; and de novo assembly, MAG binning, plus metabolic reconstruction in a polyethylene degradation study. - Across these benchmarks, the system reproduced the original studies' primary biological findings and showed high concordance, with expected tool- and database-dependent variation noted by the authors. - Robustness testing included 27 independent runs across three backbone LLMs and three prompt-complexity tiers; the system achieved a 98.8% task completion rate and produced reproducible diversity and differential-abundance estimates. - The report emphasizes scalability and adaptive, end-to-end computational workflows for **microbiome** research; the manuscript is a preprint and has not been peer reviewed, as stated by the authors.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=5CFKbshld6NrnRFQ4BQO_s65YvvWXNMqJgNFTHR0geU-1795334447.041158-1.2.1.1-FMxaUMIGX7Ecf7OOUu3cJDQ1r81gQIUqgqNoxPj.C4XQooWkeTV4ybo9cH255Csc) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.17.767465v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.17.767465v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # MicroBioAgent: an AI agent for automated microbiome analysis [ View ORCID Profile](http://orcid.org/0009-0002-0895-4354)Zeming Li, Jingjing WANG, Chonghao Wang, Yi Ding, Lu Zhang doi: https://doi.org/10.64898/2026.11.17.767465 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Zeming Li 1 Hong Kong Baptist University; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Zeming%2BLi%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Li%20Z&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AZeming%2BLi%2B) * [ORCID record for Zeming Li](http://orcid.org/0009-0002-0895-4354 "Open in new tab") Jingjing WANG 1 Hong Kong Baptist University; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jingjing%2BWANG%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=WANG%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AJingjing%2BWANG%2B) Chonghao Wang 1 Hong Kong Baptist University; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Chonghao%2BWang%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Wang%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AChonghao%2BWang%2B) Yi Ding 2 Hong Kong Baptist University (SSO) * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yi%2BDing%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Ding%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AYi%2BDing%2B) Lu Zhang 1 Hong Kong Baptist University; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lu%2BZhang%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Zhang%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALu%2BZhang%2B) * For correspondence: ericluzhang@hkbu.edu.hk * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.17.767465v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5986168/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.17.767465v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5986168/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.17.767465v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5986168/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.11.17.767465v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5986168/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.17.767465v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5986168/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Microbiome data analysis demands customized workflows tailored to specific biological questions, sequencing modalities, and data properties. However, constructing and executing these workflows requires navigating heterogeneous software dependencies, reference databases, and multi-step parameter tuning. Here, we present MicroBioAgent, an autonomous, domain-specific agent framework that translates high-level biological queries into executable, study-specific pipelines across 16S rRNA amplicon, reference-based shotgun, and de novo assembly-based metagenomics. Rather than relying on static pipeline templates, MicroBioAgent employs a closed-loop execution architecture: it dynamically selects and runs bioinformatics tools within user-controlled environments while iteratively inspecting intermediate outputs to adapt downstream analytical decisions. Furthermore, to address the long-running nature of metagenomic computation, we introduce an asynchronous background task-management mechanism that reduces LLM token consumption by over 50% while enabling real-time plan adjustment and automated workflow resumption. We systematically evaluated MicroBioAgent across three benchmarks of increasing complexity: (1) paired amplicon and shotgun profiling of tomato rhizosphere microbiomes, (2) taxonomic and functional profiling coupled with machine-learning classification in a colorectal cancer cohort, and (3) de novo metagenomic assembly, metagenome-assembled genome (MAG) binning, and metabolic pathway reconstruction in a polyethylene degradation study. Across all benchmarks, MicroBioAgent faithfully recapitulated the primary biological findings of the original studies, exhibiting high analytical concordance despite expected tool- and database-dependent variations. In systematic robustness evaluations across 27 independent runs spanning three backbone large language models and three prompt-complexity tiers, MicroBioAgent achieved a 98.8% task completion rate and yielded highly reproducible diversity and differential-abundance estimates. MicroBioAgent establishes a scalable, adaptive paradigm for end-to-end computational microbiome research. ### Competing Interest Statement The authors have declared no competing interest. Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.17.767465v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.18.767742v1 "RADSuite: Improving Species-Level Identification in Microbiome Research") Posted November 21, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.17.767465v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/21/2026.11.17.767465.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.11.17.767465v1.supplementary-material) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) MicroBioAgent: an AI agent for automated microbiome analysis Zeming Li, Jingjing WANG, Chonghao Wang, Yi Ding, Lu Zhang bioRxiv 2026.11.17.767465; doi: https://doi.org/10.64898/2026.11.17.767465 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.17.767465v1%26text%3DMicroBioAgent%253A%2520an%2520AI%2520agent%2520for%2520automated%2520microbiome%2520analysis "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.17.767465v1%26t%3DMicroBioAgent%253A%2520an%2520AI%2520agent%2520for%2520automated%2520microbiome%2520analysis "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.17.767465v1%26title%3DMicroBioAgent%253A%2520an%2520AI%2520agent%2520for%2520automated%2520microbiome%2520analysis%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.17.767465v1%26title%3DMicroBioAgent%253A%2520an%2520AI%2520agent%2520for%2520automated%2520microbiome%2520analysis "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.11.17.767465) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.11.17.767465v1&count=horizontal&via=&text=MicroBioAgent%3A%20an%20AI%20agent%20for%20automated%20microbiome%20analysis&counturl=www.biorxiv.org/content/10.64898/2026.11.17.767465v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8164) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (19027) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (15171) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (46185) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22958) * [Cancer Biology](https://www.biorxiv.org/collection/cancer-biology) (20389) * [Cell Biology](https://www.biorxiv.org/collection/cell-biology) (27670) * [Clinical Trials](https://www.biorxiv.org/collection/clinical-trials) (138) * [Developmental Biology](https://www.biorxiv.org/collection/developmental-biology) (14305) * [Ecology](https://www.biorxiv.org/collection/ecology) (21661) * [Epidemiology](https://www.biorxiv.org/collection/epidemiology) (2067) * [Evolutionary Biology](https://www.biorxiv.org/collection/evolutionary-biology) (26070) * [Genetics](https://www.biorxiv.org/collection/genetics) (16510) * [Genomics](https://www.biorxiv.org/collection/genomics) (24132) * [Immunology](https://www.biorxiv.org/co
## Related Clinical Research

- [Cell-type-resolved methylation profiling from bulk long-read sequencing across human tissues](https://medichelpline.com/clinical-feed/biorxiv-13-cell-type-resolved-methylation-analysis-using-bulk-long-read-sequencing-across.md)
- [Compartment and Environmental Gradients Shape Fungal Communities in Arid Artemisia](https://medichelpline.com/clinical-feed/biorxiv-23-compartment-associated-filtering-and-environmental-gradients-shape-fungal.md)
- [High-fat Diets Reprogram Intestinal Stem Cells and May Raise Colon Cancer Risk](https://medichelpline.com/clinical-feed/medical-news-today-0-high-fat-diets-leave-memory-in-gut-stem-cells-that-may-fuel-colon-cancer.md)
- [Structured aerobic exercise linked to lower cancer recurrence and improved survival](https://medichelpline.com/clinical-feed/medical-news-today-0-aerobic-exercise-could-help-improve-outlook-after-cancer-treatment.md)
- [Arts engagement and global wellbeing: Outcome-wide analysis from 22 countries](https://medichelpline.com/clinical-feed/medrxiv-9-the-health-and-wellbeing-impact-of-arts-engagement-a-longitudinal-outcome-wide.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.